Clinical trial
Breath Test to Assess Hepatic Metabolic Reserve and to Predict Hepatic…
NCT00375011 · Meridian Bioscience, Inc., Industry · Terminated
Key facts
| NCT number | NCT00375011 |
|---|---|
| Title | Breath Test to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in Cirrhotics |
| Official title | Use of the BreathID to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in Patients With Cirrhosis in Need of Liver Transplantation |
| Lead sponsor | Meridian Bioscience, Inc., Industry |
| Collaborators | Virginia Commonwealth University US Department of Veterans Affairs U.S. Fed Hadassah Medical Organization |
| Status | Terminated |
| Study type | Observational |
| Conditions | Cirrhosis |
| Enrollment | 200 |
| Start date | Sep 1, 2008 |
| Completion | Oct 1, 2011 |
| First posted | Sep 12, 2006 |
| Last update posted | Dec 20, 2022 |
| Countries | Israel, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: